Biogen reported $637.3M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.84B 389M
Acadia Pharmaceuticals ACAD:US $ 111.66M 9.09M
Acorda Therapeutics ACOR:US $ 33.97M 1.09M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.25B 519M
Bayer BAYN:GR 3.52B 30M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 174.32M 11.71M
Bluebird Bio BLUE:US $ 86.87M 9.9M
Bristol Myers Squibb BMY:US $ 1.67B 1.05B
Eli Lilly And LLY:US $ 1.58B 22.1M
Esperion Therapeutics ESPR:US $ 61.06M 491K
Gilead Sciences GILD:US $ 1.06B 675M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Intercept Pharmaceuticals ICPT:US $ 59.28M 11.31M
Intra Cellular Therapies ITCI:US $ 52.58M 5.76M
Marinus Pharmaceuticals MRNS:US 10.38M 4.37M
Merk MRK:US $ 2.41B 663M
Moderna Inc MRNA:US 77M 1.99M
Neurocrine Biosciences NBIX:US $ 129M 22.5M
Novartis NOVN:VX 3.52B 388M
Ptc Therapeutics PTCT:US $ 61.1M 14.36M
Puma Biotechnology PBYI:US $ 28.24M 368K
Regeneron Pharmaceuticals REGN:US $ 405.6M 102.1M
Sangamo Biosciences SGMO:US $ 16.15M 726K
Sarepta Therapeutics SRPT:US $ 71.13M 14.92M
Seattle Genetics SGEN:US $ 159.84M 1.48M
Teva Pharmaceutical TEVA:IT 848M 117M
Ultragenyx Pharmaceutical RARE:US $ 53.26M 2.22M
United Therapeutics UTHR:US $ 115.7M 43M
Vertex Pharmaceuticals VRTX:US $ 192.08M 19.77M
YTE INCY:US $ 153.79M 13.19M